| Sign In to gain access to subscriptions and/or personal tools. |
Do Antibodies Stimulate Myelin Repair in Multiple Sclerosis?
One of the major goals in the study of multiple sclerosis (MS) is to identify a beneficial therapeutic intervention that mimics the intrinsic reparative process and results in long- term clinical improvement. As yet, the therapeutic strategies tested in MS have failed to accomplish this task. However, one potential therapy that has shown some promise in rodent models of demyelination involves the administration of antibodies. Studies in var ious models of demyelination (virus-induced, autoimmune, and toxic) indicate that a sub set of autoantibodies with reactivity to CNS antigens promote remyelination. We have identified a prototypic germline IgMk monoclonal antibody, designated SCH 94.03, with reactivity to a surface antigen on oligodendrocytes that promotes CNS remyelination. This antibody has the phenotypic features of polyreactive physiological natural autoan tibodies. Additionally, treatment of MS patients with intravenous immunoglobulin, which contains these natural autoantibodies, may be efficacious in a subset of patients. We propose three mechanisms (direct stimulation of oligodendrocytes, immunomodulation, and opsonization of debris) by which polyreactive natural autoantibodies directed against CNS antigen may promote remyelination. Remyelination has the potential to not only improve conduction velocity but also may protect axons from injury and improve neuro logical function. NEUROSCIENTIST 5:19-28, 1999
Key Words: KEY WORDS Remyelination • Theiler's virus • Autoantibodies • Oligodendrocytes
The Neuroscientist, Vol. 5, No. 1,
19-28 (1999) This article has been cited by other articles:
|
||||||||||||||||
 |
|
|
 |
Sign In to gain access to subscriptions and/or personal tools.
